Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases$1. .$1
Infectious Diseases, Biodefense, Vaccine Manufacturing and Vaccines
201 - 500
💰 $200M Post-IPO Debt on 2021-05
March 13
March 13
201 - 500
🇺🇸 United States – Remote
💵 $128k - $152k / year
💰 $200M Post-IPO Debt on 2021-05
⏰ Full Time
🟡 Mid-level
🟠 Senior
🤑 Sales
January 5
201 - 500
January 3
January 3
201 - 500
🇺🇸 United States – Remote
💵 $149k - $166k / year
💰 $200M Post-IPO Debt on 2021-05
⏰ Full Time
🟠 Senior
👮♂️ Security Engineer